{"title":"Correction to Lancet Infect Dis 2024; published online Dec 16. https://doi.org/10.1016/S1473-3099(24)00648-0","authors":"","doi":"10.1016/s1473-3099(25)00004-0","DOIUrl":null,"url":null,"abstract":"<em>Shields RK, Abbo LM, Ackley R, et al. Effectiveness of ceftazidime–avibactam versus ceftolozanetazobactam for multidrug-resistant</em> Pseudomonas aeruginosa <em>infections in the USA (CACTUS): a multicentre, retrospective, observational study.</em> Lancet Infect Dis <em>2024; published online Dec 16. https://doi.org/10.1016/S1473-3099(24)00648-0</em>—In this Article, the denominator for patients treated with ceftazidime–avibactam in the second sentence of the final paragraph of the Results section should have been 177. This correction has been made to the online version as of Jan 8, 2025.","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"118 1","pages":""},"PeriodicalIF":36.4000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s1473-3099(25)00004-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Shields RK, Abbo LM, Ackley R, et al. Effectiveness of ceftazidime–avibactam versus ceftolozanetazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study. Lancet Infect Dis 2024; published online Dec 16. https://doi.org/10.1016/S1473-3099(24)00648-0—In this Article, the denominator for patients treated with ceftazidime–avibactam in the second sentence of the final paragraph of the Results section should have been 177. This correction has been made to the online version as of Jan 8, 2025.
期刊介绍：
The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.The infectious diseases journal aims to be a world-leading publication, featuring original research that advocates change or sheds light on clinical practices related to infectious diseases. The journal prioritizes articles with the potential to impact clinical practice or influence perspectives. Content covers a wide range of topics, including anti-infective therapy and immunization, bacterial, viral, fungal, and parasitic infections, emerging infectious diseases, HIV/AIDS, malaria, tuberculosis, mycobacterial infections, infection control, infectious diseases epidemiology, neglected tropical diseases, and travel medicine. Informative reviews on any subject linked to infectious diseases and human health are also welcomed.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
